Alabama Board of Pharmacy Proposing Two Compounding Rules
Comments Open Until August 4, 2017
IACP Alabama Members:
The Alabama Board of Pharmacy is proposing two rules pertaining to compounding. The first clarifies guidelines for compounding parenteral sterile therapy.
The second would require pharmacists and pharmacies engaged in compounding to comply with all current and applicable U.S. Pharmacopeial Convention (USP) requirements including USP Chapter <800>.
Please note - Comments for both proposed rules are due by August 4, 2017.
Comments can be directed to Wendy Passmore at the Alabama Board of Pharmacy Until August 4, 2017. Please present your views in writing, fax or email.
Wendy Passmore Legal/Executive Assistant: 111 Village Street, Birmingham, AL 35242. Phone: 205/981-4764; Fax: 205/803-6481; Email: wpassmore@albop.com
Details and links are below:
Alabama - Parenteral Therapy - Citation: 680-X-2-.19
Comments/Briefs Due: 8/4/2017
Summary: The Board of Pharmacy has proposed amendments to clarify guidelines for parenteral sterile therapy
History: Comment deadline: 08/04/17; N
otice of Intended Action published on 06/30/17
Alabama - Requirements for Compounding - Citation: 680-X-2-.43
Comments/Briefs Due: 8/4/2017
Summary: The Board of Pharmacy has proposed a new rule to reinforce the requirements that all pharmacies and pharmacists that engage in compounding of drugs must comply with all applicable and current requirements of U.S. Pharmacopeial Convention (USP) - National Formulary USP-NF.
History: Comment deadline: 08/04/17
Notice of Intended Action published on 06/30/17